IPP Bureau
Apollo Hospitals Bangalore first to hit a century of robotic cardiac surgeries
By IPP Bureau - September 07, 2021
In comparison to traditional open-heart surgery, which involves opening up the chest by splitting the breastbone, da Vinci Xi's innovative technology allows for complex cardiovascular surgeries to be performed through smaller incisions and precise motion control
Sharp develops Plasmacluster tech that reduces airborne novel coronavirus
By IPP Bureau - September 07, 2021
Plasmacluster technology significantly inactivates SARS-CoV-2 contained in adherent saliva in an environment with 60% humidity where the physiological protective function is maintained
Healthium Medtech files DRHP for IPO
By IPP Bureau - September 07, 2021
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
Dr Reddy’s launches Minoxidil for women
By IPP Bureau - September 07, 2021
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant
By IPP Bureau - September 07, 2021
ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency
HUL funds study on Covid-19 vulnerability and vaccine efficiency
By IPP Bureau - September 07, 2021
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Max Ventilator forms partnership with US-based Amptron Medical
By IPP Bureau - September 07, 2021
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
Anti-dumping duty proposed on Vitamin C from China for five years
By IPP Bureau - September 07, 2021
The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports
Brinton launches Hohner Health in India
By IPP Bureau - September 06, 2021
The focus is on wellness and personal care products
Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19
By IPP Bureau - September 06, 2021
Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence
TB Alliance partners with Lupin for non-exclusive anti-TB drug
By IPP Bureau - September 06, 2021
According to WHO, over 1.5 million people died of TB in 2020
Zydus Cadila’s Sitagliptin base tablets receive tentative approval from US FDA
By IPP Bureau - September 06, 2021
Zydus’ Sitagliptin base contains the active moiety Sitagliptin in a different form than used in the branded reference product, Januvia (Sitagliptin Phosphate)
CRAMS to drive growth for Indian pharma industry: report
By IPP Bureau - September 06, 2021
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
DGCI approves Hetero’s Tocilizumab
By IPP Bureau - September 06, 2021
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
Accutest enables NMPA approval for Qilu’s Abiraterone
By IPP Bureau - September 06, 2021
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
